Digestive & Intestinal Remedies (Pharmacies) - Africa

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$744.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.13%, resulting in a market volume of US$955.90m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.57 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Africa has been experiencing significant growth in recent years. Customer preferences for over-the-counter remedies, coupled with increasing awareness about digestive health, have been driving this growth. Additionally, local special circumstances and underlying macroeconomic factors have also played a role in shaping the market. Customer preferences in Africa have been shifting towards self-medication and seeking remedies from pharmacies. This is partly due to the convenience and accessibility of pharmacies, as well as the increasing availability of a wide range of digestive and intestinal remedies. Customers are becoming more proactive in managing their digestive health and are seeking quick and effective solutions for common ailments such as indigestion, heartburn, and constipation. Trends in the market indicate a growing demand for natural and herbal remedies. African consumers have shown a preference for traditional and plant-based medicines, believing them to be safer and more effective than synthetic alternatives. This has led to an increase in the availability and variety of herbal digestive remedies in pharmacies across the region. Additionally, there is a growing trend of consumers seeking products that address specific digestive issues, such as probiotics for gut health or enzymes for better digestion. Local special circumstances in Africa, such as a high prevalence of gastrointestinal diseases and dietary challenges, have contributed to the growth of the Digestive & Intestinal Remedies market. The region has a higher incidence of diseases such as diarrhea, irritable bowel syndrome, and gastroesophageal reflux disease. This has created a demand for effective remedies that can alleviate symptoms and improve overall digestive health. Furthermore, dietary challenges such as limited access to clean water and poor sanitation practices can also contribute to digestive issues, leading to an increased need for remedies. Underlying macroeconomic factors, such as population growth and rising disposable incomes, have also fueled the growth of the Digestive & Intestinal Remedies market in Africa. As the population continues to increase, so does the demand for healthcare products and services. Additionally, rising disposable incomes have made healthcare more affordable and accessible to a larger segment of the population, leading to increased spending on digestive remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Africa is developing due to customer preferences for over-the-counter remedies, increasing awareness about digestive health, and the availability of a wide range of products. Local special circumstances, such as a high prevalence of gastrointestinal diseases and dietary challenges, have further contributed to the growth of the market. Underlying macroeconomic factors, including population growth and rising disposable incomes, have also played a role in fueling the market's development. As the market continues to evolve, it is expected to witness further growth and innovation in response to changing customer needs and preferences.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.